# Hyperpolarised 13C-Pyruvate MRI Study

> **NCT03687645** · NA · UNKNOWN · sponsor: **University College, London** · enrollment: 25 (estimated)

## Conditions studied

- Cancer
- Cardiovascular Diseases

## Interventions

- **DIAGNOSTIC_TEST:** Hyperpolarised MRI

## Key facts

- **NCT ID:** NCT03687645
- **Lead sponsor:** University College, London
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-07-01
- **Primary completion:** 2020-06-30
- **Final completion:** 2020-06-30
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2018-09-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03687645

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03687645, "Hyperpolarised 13C-Pyruvate MRI Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03687645. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*